Pallas Health review
Pallas Health is a rare thing in this category: a platform that sells both the inexpensive compounded route and the genuine FDA-approved pens, and is straightforward about the price of each. Compounded semaglutide averages about $199 a month and tirzepatide $299, while brand Zepbound is $1,069, Ozempic $1,299, and Wegovy and Mounjaro $1,349 each, all cash-pay. Its own FAQ answers the question that matters most on a titration schedule — does the price rise with the dose — with a flat no, and the clinician, dose adjustments, check-ins and messaging are all inside the plan price with no membership fee. Three separate claims held up under independent checking: two named clinicians are active in the federal NPI registry, the LegitScript seal returns a live image where an invented ID returns an error, and no FDA warning letter is attributable to the company. The reservations are specific rather than sweeping — billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is not billed at all.
then $199/mo ongoing
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Pallas Health at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- All 50 states + D.C. (async in 43)
- Brand-name
- Yes
How we scored Pallas Health
Each factor is scored from Pallas Health's real pricing, disclosures and oversight, then combined into the 78/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Reasonable oversight, though some program details aren't fully public.
The core price is disclosed, but some conditions or add-ons aren't upfront.
Little here is shaped around a mother's week or her life stage.
Follow-up, titration help, and messaging are genuinely part of the package.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- www.pallashealth.co
Prices read from Pallas's own published copy: compounded semaglutide $139 first month then $597 every 12 weeks (its stated $199/mo average), compounded tirzepatide $179 then $897 every 12 weeks ($299/mo average), and cash-pay brand Zepbound $1,069, Ozempic $1,299, Wegovy $1,349 and Mounjaro $1,349. Pallas states the price does not rise with dose, that it is cash-pay and not billed to insurance, and that there is no separate membership fee. Coverage is all 50 states plus D.C., asynchronous in 43 of them. Two named clinicians were checked in the federal NPI registry rather than taken on trust: Ana Lisa Carr, MD (NPI 1689841744, Family Medicine, Franklin TN, active) and Kelly Tenbrink (NPI 1346482684, Emergency Medicine, Atlantis FL, active); a similarly-named Ana Carr who is an optometrist in San Antonio is a different person and was excluded. The LegitScript seal it displays (ID 49989444) returns a live image from LegitScript's own domain, while an invented seal ID returns 403 in the same check — so the badge is real. No FDA warning letter is attributable to Pallas: narrow searches returned zero with a known positive control returning in the same pass. Its compounding pharmacy is not named anywhere on the site.
What to expect when you sign up
We walked Pallas Health's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Both compounded and brand-name prices are published openly on the homepage
- 2Start a visit; a US-licensed clinician decides eligibility
- 3Care is asynchronous in 43 of 50 states — messaging rather than a scheduled call
- 4Free shipping, and medication dispatched only once prescribed
What we noticed
- The 12-week billing cycle is the real cadence; the monthly figures are Pallas's own averages of it
- Its FAQ answers the dose-escalation pricing question directly and in the negative
- A specific refund policy is published, including a $5 processing fee on qualifying cancellations
- Named clinicians and a LegitScript ID that both survive independent checking
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $139 → $199 | All doses (billed every 12 weeks)$139 for your first month, then $597 every 12 weeks — Pallas publishes that as a $199/mo average. Same price at every dose, and the clinician, dose adjustments, check-ins and care-team messaging are all in it. |
| Compounded tirzepatide | $179 → $299 | All doses (billed every 12 weeks)$179 for your first month, then $897 every 12 weeks, published as a $299/mo average. Flat at every dose, with provider care included. |
| Brand tirzepatide | $1069 | Zepbound (brand-name)Real FDA-approved Zepbound at a cash-pay price, on the same platform as the compounded plans. |
| Brand semaglutide | $1299 | Ozempic (brand-name)Cash-pay brand Ozempic. Not billed to insurance — Pallas is cash-pay only. |
| Brand semaglutide | $1349 | Wegovy (brand-name)Cash-pay brand Wegovy, the on-label weight-loss semaglutide. |
| Brand tirzepatide | $1349 | Mounjaro (brand-name)Cash-pay brand Mounjaro. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Pallas Health's public disclosures at last review and change often; confirm the current number on Pallas Health's own site.
What we like
- Compounded and brand-name GLP-1s side by side on one platform, each priced openly
- Flat pricing at every dose, answered directly in the site's own FAQ
- All 50 states plus D.C., asynchronous in 43 of them
- Two named clinicians verified active in the federal NPI registry
- LegitScript seal confirmed genuine against an invented-ID control
- A published, specific refund policy rather than a marketing promise
The caveats
- Bills every 12 weeks ($597 / $897) — the monthly figures are Pallas's own averages
- The compounding pharmacy is never named
- Cash-pay only; insurance is never billed, so brand prices are full freight
- A $5 processing fee plus processing costs applies to qualifying cancellation refunds
- Seven states still require one live video visit
- No postpartum, breastfeeding or PCOS guidance on the site
Pallas Health for mothers: our verdict
Pallas Health is a rare thing in this category: a platform that sells both the inexpensive compounded route and the genuine FDA-approved pens, and is straightforward about the price of each. Compounded semaglutide averages about $199 a month and tirzepatide $299, while brand Zepbound is $1,069, Ozempic $1,299, and Wegovy and Mounjaro $1,349 each, all cash-pay. Its own FAQ answers the question that matters most on a titration schedule — does the price rise with the dose — with a flat no, and the clinician, dose adjustments, check-ins and messaging are all inside the plan price with no membership fee. Three separate claims held up under independent checking: two named clinicians are active in the federal NPI registry, the LegitScript seal returns a live image where an invented ID returns an error, and no FDA warning letter is attributable to the company. The reservations are specific rather than sweeping — billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is not billed at all. The advertised entry is $139, but the standing rate settles near $199/month — so read the headline as a starting offer, not the real monthly cost.
We weigh Pallas Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What Pallas Health actually costs
- Compounded semaglutide — All doses (billed every 12 weeks): $139 to start, then $199/mo
- Compounded tirzepatide — All doses (billed every 12 weeks): $179 to start, then $299/mo
- Brand-name tirzepatide — Zepbound (brand-name): $1069/mo
- Brand-name semaglutide — Ozempic (brand-name): $1299/mo
- Brand-name semaglutide — Wegovy (brand-name): $1349/mo
- Brand-name tirzepatide — Mounjaro (brand-name): $1349/mo
That's roughly in line with the ~$175/month median across our roster.
The medications Pallas Health prescribes
Pallas Health prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
Where Pallas Health fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you want frictionless cancellation — the fine print here is where the complaints cluster.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Pallas Health's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Pallas Health is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Readers comparing compounded against FDA-approved products who want both from one provider, and who value named clinicians and a published refund policy over the cheapest possible headline.
Alternatives to Pallas Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Pallas Health
Head-to-head & alternatives
Pallas Health, answered
- What does Pallas actually charge?
- Compounded semaglutide is $139 for the first month and then $597 every 12 weeks — a $199/mo average by Pallas's own arithmetic. Tirzepatide is $179, then $897 every 12 weeks, or $299/mo averaged. Brand-name is cash-pay: Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 each. The compounded figures include the clinician, dose adjustments, check-ins and messaging, with no membership fee, and the price does not rise with the dose.
- Why list a monthly price when it bills quarterly?
- Because the monthly average is the only figure comparable to the rest of this page, and Pallas publishes it itself. But the charge lands as $597 or $897 every 12 weeks, which is a materially different thing for a household budget than a monthly debit — so it is stated plainly here rather than buried. The first month is genuinely cheaper at $139 or $179, and that intro rate is not the ongoing rate.
- Is the LegitScript badge real?
- Yes, and it was checked rather than assumed. The seal ID Pallas displays returns a live image from LegitScript's own domain, while an invented seal ID returns a 403 error in the same check — which is how a fabricated badge gives itself away. Two of the clinicians it names also verify as active in the federal NPI registry. Against that, no compounding pharmacy is named anywhere on the site, which is the one meaningful disclosure gap.
- Can I use insurance?
- No. Pallas is cash-pay only and states it does not bill insurance under any circumstance. That is worth weighing carefully if you have coverage that would pay for brand-name Wegovy or Zepbound, because Pallas's own cash prices for those — $1,349 and $1,069 — are what a plan with prior authorisation might reduce substantially elsewhere. The compounded route is where its pricing is genuinely competitive.
Pricing, states and verification reflect Pallas Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.